Evidence map›Paper›PMID 41699086›Full record

Articlenpj antimicrobials and resistance2026

Global response to antibiotic exposure reveals a critical role for nucleotide metabolism in high-level β-lactam tolerance.

Megan Renee Keller, Misha Iqbal Kazi, Anas Saleh, Upasana Basu, Jung-Ho Shin, Kyu Rhee, Tobias Dörr

Abstract read
In one paragraph

Article in npj antimicrobials and resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Megan Renee KellerWeill Institute for Cell and Molecular Biology, Cornell University, Ithaca, NY, USA.
Misha Iqbal KaziWeill Institute for Cell and Molecular Biology, Cornell University, Ithaca, NY, USA.
Anas SalehDepartment of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, New York, NY, USA.
Upasana BasuWeill Institute for Cell and Molecular Biology, Cornell University, Ithaca, NY, USA.
Jung-Ho ShinWeill Institute for Cell and Molecular Biology, Cornell University, Ithaca, NY, USA.
Kyu RheeDepartment of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, New York, NY, USA.
Tobias DörrWeill Institute for Cell and Molecular Biology, Cornell University, Ithaca, NY, USA. tdoerr@cornell.edu.

Funding

Tri-I Training Program in MetabolomicsR25AI140472 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI Kyu Y Rhee · 2019 to 2026
$2.4M
NIAID NIH HHS R25 AI140472
6 · The paper itself

Abstract

Antibiotic tolerance, the ability to survive lethal antibiotics for a prolonged period of time is a rising threat due to its role as a steppingstone towards antibiotic resistance. While tolerance has been recognized as a severe clinical threat, little is known about the mechanisms promoting tolerance. Here, we delineated the physiology of antibiotic tolerance to the classic β-lactam antibiotic, penicillin, to discover the metabolic underpinnings of how tolerant bacteria survive ordinarily lethal antibiotic exposure. We used transcriptomics and metabolomics in the hypertolerant Gram-negative cholera pathogen, Vibrio cholerae, to identify the global regulatory and metabolic response to antibiotic exposure. Key pathways like central carbon metabolism, cell wall synthesis, heat shock, two-component systems, and particularly nucleotide synthesis were significantly altered in response to penicillin. Most notably, nucleotide levels were depleted upon antibiotic exposure, concomitant with upregulation of both purine and pyrimidine synthesis functions. Consistent with a crucial role for nucleotide synthesis in tolerance, we find that targeting nucleotide synthesis synergizes with β-lactam-mediated killing in hypertolerant V. cholerae, Klebsiella pneumoniae and E. coli. These datasets thus reveal new vulnerabilities in tolerant bacteria that can serve as conceptual scaffolds for drug development and for improving antibiotic efficacy.

Identifiers

PMID41699086
PMCPMC12909929

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.